HealthCor Management, L.P. - Q4 2014 holdings

$1.79 Billion is the total value of HealthCor Management, L.P.'s 52 reported holdings in Q4 2014. The portfolio turnover from Q3 2014 to Q4 2014 was 87.8% .

 Value Shares↓ Weighting
MNKKQ SellMALLINCKRODT PUB LTD CO$131,215,000
-19.1%
1,325,000
-26.4%
7.31%
-12.2%
GILD NewGILEAD SCIENCES INC$117,825,0001,250,000
+100.0%
6.57%
PFE NewPFIZER INC$100,275,0003,219,100
+100.0%
5.59%
VRX NewVALEANT PHARMACEUTICALS INTL$93,022,000650,000
+100.0%
5.18%
A BuyAGILENT TECHNOLOGIES INCcall$73,692,000
+158.7%
1,800,000
+260.0%
4.11%
+180.8%
HZNP BuyHORIZON PHARMA PLC$72,184,000
+64.4%
5,600,000
+56.6%
4.02%
+78.5%
KEYS NewKEYSIGHT TECHNOLOGIES INC$69,020,0002,043,826
+100.0%
3.85%
ILMN NewILLUMINA INC$64,603,000350,000
+100.0%
3.60%
SLXP SellSALIX PHARMACEUTICALS INC$60,344,000
-58.7%
525,000
-43.9%
3.36%
-55.2%
LH NewLABORATORY CORP AMER HLDGS$59,345,000550,000
+100.0%
3.31%
MDVN BuyMEDIVATION INC$57,276,000
+10.3%
575,000
+9.5%
3.19%
+19.8%
TMO BuyTHERMO FISHER SCIENTIFIC INC$50,116,000
+644.7%
400,000
+623.3%
2.79%
+707.2%
UHS SellUNIVERSAL HLTH SVCS INCcl b$50,067,000
-4.2%
450,000
-10.0%
2.79%
+4.0%
OCR BuyOMNICARE INC$49,228,000
+125.9%
675,000
+92.9%
2.74%
+145.2%
WBMD SellWEBMD HEALTH CORP$48,449,000
-9.6%
1,225,000
-4.4%
2.70%
-1.8%
BSX NewBOSTON SCIENTIFIC CORP$45,861,0003,461,200
+100.0%
2.56%
ZBH NewZIMMER HLDGS INCcall$45,368,000400,000
+100.0%
2.53%
HYH NewHALYARD HEALTH INC$43,233,000950,800
+100.0%
2.41%
ISRG SellINTUITIVE SURGICAL INC$40,517,000
-59.2%
76,600
-64.4%
2.26%
-55.7%
MYL SellMYLAN INC$39,391,000
-44.1%
698,800
-54.9%
2.20%
-39.4%
TSRO SellTESARO INC$39,050,000
+21.0%
1,050,000
-12.4%
2.18%
+31.4%
MCK SellMCKESSON CORP$36,451,000
-31.9%
175,600
-36.1%
2.03%
-26.1%
NUVA SellNUVASIVE INC$35,370,000
-15.5%
750,000
-37.5%
1.97%
-8.3%
DHR NewDANAHER CORP DELcall$34,284,000400,000
+100.0%
1.91%
XLV SellSELECT SECTOR SPDR TRput$34,190,000
-46.5%
500,000
-50.0%
1.91%
-41.9%
CAH NewCARDINAL HEALTH INC$31,097,000385,200
+100.0%
1.73%
ZBH NewZIMMER HLDGS INC$29,988,000264,400
+100.0%
1.67%
AMRI BuyALBANY MOLECULAR RESH INC$26,048,000
-15.7%
1,600,000
+14.3%
1.45%
-8.5%
ALXN SellALEXION PHARMACEUTICALS INC$23,517,000
-5.5%
127,100
-15.3%
1.31%
+2.7%
ZTS NewZOETIS INCcl a$22,053,000512,500
+100.0%
1.23%
CELG NewCELGENE CORP$20,314,000181,600
+100.0%
1.13%
BKD BuyBROOKDALE SR LIVING INC$20,297,000
+34.0%
553,500
+17.8%
1.13%
+45.4%
VSAR BuyVERSARTIS INC$19,644,000
+37.9%
875,000
+16.7%
1.10%
+49.8%
TEVA NewTEVA PHARMACEUTICAL INDS LTDadr$16,333,000284,000
+100.0%
0.91%
PFE NewPFIZER INCcall$15,575,000500,000
+100.0%
0.87%
PCRX NewPACIRA PHARMACEUTICALS INC$11,083,000125,000
+100.0%
0.62%
AKBA SellAKEBIA THERAPEUTICS INC$9,839,000
-50.6%
845,254
-6.1%
0.55%
-46.4%
A SellAGILENT TECHNOLOGIES INC$9,805,000
-83.6%
239,500
-77.2%
0.55%
-82.2%
VAR NewVARIAN MED SYS INCput$8,651,000100,000
+100.0%
0.48%
DSCI  DERMA SCIENCES INC$8,565,000
+11.8%
920,0000.0%0.48%
+21.1%
DHR SellDANAHER CORP DEL$4,500,000
-93.4%
52,500
-94.2%
0.25%
-92.9%
NVAX BuyNOVAVAX INC$3,853,000
+56.6%
649,781
+10.1%
0.22%
+70.6%
INFI SellINFINITY PHARMACEUTICALS INC$3,778,000
-75.8%
223,712
-80.8%
0.21%
-73.7%
IDRA SellIDERA PHARMACEUTICALS INC$3,565,000
+83.1%
808,292
-4.9%
0.20%
+99.0%
KYTH NewKYTHERA BIOPHARMACEUTICALS I$3,177,00091,600
+100.0%
0.18%
CLDX NewCELLDEX THERAPEUTICS INC NEW$2,986,000163,600
+100.0%
0.17%
KERX NewKERYX BIOPHARMACEUTICALS INC$2,523,000178,300
+100.0%
0.14%
ELOS BuySYNERON MEDICAL LTD$2,458,000
+7.2%
263,400
+15.1%
0.14%
+16.1%
XOMA BuyXOMA CORP DEL$1,616,000
+152.5%
450,000
+196.1%
0.09%
+172.7%
ACHN SellACHILLION PHARMACEUTICALS INcall$1,225,000
-75.5%
100,000
-80.0%
0.07%
-73.4%
BLCM NewBELLICUM PHARMACEUTICALS INC$935,00040,586
+100.0%
0.05%
CEMP NewCEMPRA INC$268,00011,408
+100.0%
0.02%
AERI ExitAERIE PHARMACEUTICALS INC$0-75,000
-100.0%
-0.08%
WMGIZ ExitWRIGHT MED GROUP INCright 03/01/2019$0-725,000
-100.0%
-0.08%
SNSS ExitSUNESIS PHARMACEUTICALS INC$0-532,500
-100.0%
-0.20%
CSII ExitCARDIOVASCULAR SYS INC DEL$0-167,900
-100.0%
-0.20%
XOMA ExitXOMA CORP DELcall$0-1,000,000
-100.0%
-0.22%
P103PS ExitNPS PHARMACEUTICALS INCcall$0-400,000
-100.0%
-0.53%
RGLS ExitREGULUS THERAPEUTICS INC$0-1,550,000
-100.0%
-0.54%
ARIA ExitARIAD PHARMACEUTICALS INC$0-2,365,000
-100.0%
-0.66%
AEGR ExitAEGERION PHARMACEUTICALS INC$0-463,700
-100.0%
-0.80%
B108PS ExitACTAVIS PLC$0-150,000
-100.0%
-1.86%
VRTX ExitVERTEX PHARMACEUTICALS INCcall$0-350,000
-100.0%
-2.02%
HCA ExitHCA HOLDINGS INC$0-625,000
-100.0%
-2.26%
AGN ExitALLERGAN INC$0-250,300
-100.0%
-2.29%
B108PS ExitACTAVIS PLCcall$0-200,000
-100.0%
-2.48%
CTRX ExitCATAMARAN CORP$0-1,500,000
-100.0%
-3.25%
BIIB ExitBIOGEN IDEC INC$0-200,000
-100.0%
-3.40%
CBST ExitCUBIST PHARMACEUTICALS INC$0-1,100,000
-100.0%
-3.75%
SPY ExitSPDR S&P 500 ETF TRput$0-400,000
-100.0%
-4.05%
T107PS ExitWRIGHT MED GROUP INC$0-3,150,000
-100.0%
-4.90%
MDRX ExitALLSCRIPTS HEALTHCARE SOLUTN$0-7,210,000
-100.0%
-4.97%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2015-02-17
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
HCA HOLDINGS INC27Q1 20226.2%
ZIMMER HLDGS INC26Q2 20229.3%
DANAHER CORPORATION26Q3 20225.6%
NEUROCRINE BIOSCIENCES INC26Q4 20227.8%
UNITEDHEALTH GROUP INC24Q3 20226.4%
VERTEX PHARMACEUTICALS INC24Q3 20215.3%
HUMANA INC22Q3 20226.6%
BRISTOL-MYERS SQUIBB CO22Q3 20229.2%
BIOGEN INC21Q3 20228.5%
LABORATORY CORP AMER HLDGS20Q2 20208.3%

View HealthCor Management, L.P.'s complete holdings history.

Latest significant ownerships (13-D/G)
HealthCor Management, L.P. Q4 2014 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
CareView Communications IncMay 26, 2023186,970,00032.0%
Research Alliance Corp. IISold outFebruary 14, 202300.0%
ARYA Sciences Acquisition Corp IVSold outFebruary 14, 202200.0%
Aurinia Pharmaceuticals Inc.Sold outFebruary 14, 202200.0%
MADRIGAL PHARMACEUTICALS, INC.Sold outFebruary 14, 202200.0%
Medicus Sciences Acquisition Corp.Sold outFebruary 14, 202200.0%
Arcturus Therapeutics Holdings Inc.Sold outFebruary 12, 202100.0%
Intersect ENT, Inc.Sold outFebruary 12, 202100.0%
NEVRO CORPFebruary 12, 2021156,0460.5%
ViewRay, Inc.Sold outFebruary 12, 202100.0%

View HealthCor Management, L.P.'s complete significant-ownership history.

Latest filings
TypeFiled
42023-05-26
42023-05-26
SC 13D/A2023-05-26
42023-04-04
42023-04-04
SC 13D/A2023-04-03
13F-HR2023-02-15
SC 13G/A2023-02-14
42023-01-04
42023-01-04

View HealthCor Management, L.P.'s complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (1794065000.0 != 1794069000.0)

Export HealthCor Management, L.P.'s holdings